Friday, September 17, 2010
Johns Hopkins Hospital Shooting: Doctor Wounded, Gunman Barricaded, Say Reports
BALTIMORE (CBS/AP) Baltimore police say a lone gunman shot a doctor on the eighth floor of a Johns Hopkins Hospital building in Baltimore, was believed to have barricaded himself in a relative's hospital room.
There were conflicting reports about whether the shooting suspect was still at-large.
Parts of the Nelson Building, the main tower at Johns Hopkins, was put on lockdown around 11:15 a.m. Thursday, and other sections of the East Baltimore hospital campus were evacuated, after reports of shots being fired, according to The Baltimore Sun.
A nurse who worked on the floor where the injured doctor was shot told the paper that the gunman was unhappy about the way his mother was being treated and had threatened to jump out of a window when the shooting occurred.
"I started running," The nurse told the Sun. "When you hear gunshots you run."
Baltimore police said they were setting up a tactical operation to deal with a gunman who is holed up on the eighth floor.
The doctor was rushed to surgery and is expected to survive, police spokesman Anthony Guglielmi said. He said he did not know the relationship between the gunman and the doctor.
The hospital said in a statement that the doctor is a faculty physician but it could not release more information because of privacy policies.
A spokesman for Johns Hopkins hospital in Baltimore earlier said the gunman had been caught, but Guglielmi says that's not the case.
Guglielmi said some parts of the hospital were being evacuated, but not the entire massive complex in east Baltimore. He says he doesn't know the doctor's condition.
"The doctor will be OK," Guglielmi said. "He's in the best place in the world - at Johns Hopkins hospital."
研究:葡萄糖胺和軟骨素治關節痛無效
更新日期:2010/09/17 09:35
(路透倫敦17日電)根據瑞士科學家的研究報告,全球數百萬人用來治療關節疼痛的2種營養補充劑,事實上並無效用,而且衛生部門或保險業者不應該為此支付費用。
這2種補充劑分別是葡萄糖胺和軟骨素,它們可單獨或合併使用,以降低髖關節炎和膝關節炎所造成的疼痛。
不過瑞士研究人員觀察3803名膝關節和髖關節炎患者的實驗後發現,不論是軟骨素、葡萄糖胺亦或是2者合併使用,對關節疼痛都「沒有臨床相關的影響」。
瑞士伯恩大學(University of Bern)的研究作者朱尼(Peter Juni)說:「衛生機關和健保業者不應該為這些藥劑支付費用,並且要阻止開新的處方給還未接受治療的病患。」
骨關節炎是美國最常見的關節炎類型,並且也是引發慢性失能的主要原因之一。受到骨關節炎所苦的患者在英國有大約800萬人、在美國則有將近2700萬人。中央社(翻譯)
(路透倫敦17日電)根據瑞士科學家的研究報告,全球數百萬人用來治療關節疼痛的2種營養補充劑,事實上並無效用,而且衛生部門或保險業者不應該為此支付費用。
這2種補充劑分別是葡萄糖胺和軟骨素,它們可單獨或合併使用,以降低髖關節炎和膝關節炎所造成的疼痛。
不過瑞士研究人員觀察3803名膝關節和髖關節炎患者的實驗後發現,不論是軟骨素、葡萄糖胺亦或是2者合併使用,對關節疼痛都「沒有臨床相關的影響」。
瑞士伯恩大學(University of Bern)的研究作者朱尼(Peter Juni)說:「衛生機關和健保業者不應該為這些藥劑支付費用,並且要阻止開新的處方給還未接受治療的病患。」
骨關節炎是美國最常見的關節炎類型,並且也是引發慢性失能的主要原因之一。受到骨關節炎所苦的患者在英國有大約800萬人、在美國則有將近2700萬人。中央社(翻譯)
Subscribe to:
Posts (Atom)